Synthesis of (Z) and (E) α - Alkenyl phosphonic acid derivatives of purines and pyrimidines

Tetrahedron

Volumn 54, Issue 15, 1998, Pages 3807-3816

  Lazrek, H B ^a   Rochdi, A ^a   Khaider, H ^a   Barascut, J L ^b   Imbach, J L ^b   Balzarini, J ^c   Witvrouw, M ^c   Pannecouque, C ^c   De Clercq, E ^c  

^a FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

^b UNIV MONTPELLIER   (France)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 (5 FLUOROURACIL 1 YL)ETHYLEN 1 PHOSPHONIC ACID; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CHEMICAL REACTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; T LYMPHOCYTE; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0032499017     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(98)00107-0     Document Type: Article

References (36)

1. 2. McGuigan, C.; Shaaka, H.; Mahmood, N.; Hay, A. Bioorg. Med. Chem. Lett., 1993, 3, 1203-1206.
2. 3. Périgaud, C.; Girardet, J,-L.; Gosselin, G.; Imbach, J.-L. In: Advances in Antiviral Drug Design, 1996. vol. 2, De Clercq, E., ed. JAI Press Inc., Greenwich, CT, 147-172.
3. 4. Harnden, M.R.; Jarvest, R.L. Bioorg. Med. Chem. Lett., 1992, 2, 1559-1560.
4. 5. Naesens, L; Balzarini, J.; De Clercq, E. Drug, Metab. Dispos., 1992, 20, 747-752.
5. 6. Balzarini, J.; Holy, A.; Jindrich, J.; Naesens, L.; Snoeck, R.; Schols, D.; De Clercq, E. Antimicrob. Agents Chemother., 1993, 37, 332-338.
6. 7. Dvorakova, H.; Masojidkova, M.; Holý, A.; Balzarini, J.; Andrei, G.; Snoeck, R.; De Clercq, E. J. Med. Chem., 1996, 39, 3263-3268.
7. 8. Chamberlain, S.D.; Biron, K.K.; Dornsife, R.E.; Averett, D.R.; Beauchamp, L.; Koszalka, G.W. J. Med. Chem., 1994, 37, 1371-1377.
8. 9. Kim, C.U.; Luh, B.Y.; Misco, P.F.; Bronson, J.J.; Hitchcock, M.J.M.; Ghazzouli, I.; Martin, J.C. J. Med. Chem. 1990, 33, 1207-1213.
9. 10. Kim, C.U.; Misco, P.F.; Martin, J.C. Heterocycles, 1990, 31, 1571-1574.
10. 11. Parkin, A. J. Chem. Soc. Perkin Trans. I, 1991, 2983-2990.
11. 12. Harnden, M.R., Jennings, L.J. Antiviral Chem. Chemother., 1993, 4, 215-227.
12. 13. Balzarini, J.; De Clercq, E. Antiviral Chemotherapy, ed Jeffries, D.J. and De Clercq, E. 1995, 2, 41-63.
13. 14. Labataille, P.; Pélicano, H.; Maury, G.; Imbach, J.-L.; Gosselin, G. Bioorg. Med. Chem. Lett., 1995, 3, 2315-2320.
14. 15. Racha, S.; Vargeese, C.; Vemishetti, P.; EL-Subbagh, H.I.; Abushanab, E.; Panzica, R.P. J. Med. Chem., 1996, 39, 1130-1135.
15. 16. Yu, K.-L., Bronson, J.J.; Yang, H.; Patick, A.; Alam, M.; Brankovan, V.; Datema, R.; Hitchcock, M.J.M.; Martin, J.C. J. Med. Chem. 1992, 35, 2958-2969.
16. 17. Harnden, M.R.; Jarvest, R.L.; Parrat, M.J. J. Chem. Soc. Perkin Trans I, 1992, 2259-2263.
17. 18. Secrist III, J.A.;. Riggs, R.M; Comber, R.N.; Montgomery, J.A. Nucleosides & Nucleotides, 1992, 11, 947-956.
18. 19. Vellemin, D.; Starzyk, F.I. Synthetic. Commun., 1993, 23, 1053-1059.
19. 20. Megati, S.; Phadtare, S.; Zemlicka, J. J. Org. Chem., 1992, 57, 2320-2327.
20. 21. Harnden, M.R.; Parkin, A.;. Parratt, M.J.; Perkins, R.M. J. Med. Chem., 1993, 36, 1343-1355.
21. 22. Balzarini, J.; De Clercq, E J. Biol. Chem., 1991, 266, 8686-8689.
22. 23. Sisky, M. S.; Bass, R. G. J. Heterocyclic Chem., 1984, 21, 759-768.
23. 24. Winterfeldt, E.; Preuss, H. Chem. Ber., 1966, 99, 450-458.
24. 25. Bram, G.; Sansoulet, J.. Galons, H.; Miocque, M; Synthetic Commun., 1988, 18, 367-380.
25. 26. Lazrek, H.B.; khaider, H.; Rochdi, A.; Barascut, J.-L.; Imbach, J.-L. Nucleosides & Nucleotides, 1994, 13, 811-817.
26. 27. Lazrek, H.B.; Taourirte, M.; Barascut, J.-L.; Imbach, J.-L. Nucleosides & Nucleotides, 1991, 10, 1285-1293
27. 28. Taha, M. L.; Lazrek, H.B. Bull. Soc. Chim. Belg. 1995, 104, 591-594.
28. 29. Lazrek, H.B.; Taourirte, M.; Barascut, J.-L.; Imbach, J.-L. Bull. Soc. Chim. Belg. 1996, 105, 391-395.
29. 30. Lazrek, H.B.; Taourirte, M.; Barascut, J.-L.; Imbach, J.-L. Bull. Soc. Chim. Belg. 1997, 106, 19-24.
30. 31. Lazrek, H.B.; Cissoko, S., I.; Barascut, J.-L.; Imbach, J.-L. in preparation.
31. 32. Scheiner, P.; Geer, A.; Bucknor, A.M.; Gadler, H.; Price, R.W. Nucleosides & Nucleotides, 1989. 8, 1441-1451.
32. 33. Scheiner, P.; Geer, A.; Bucknor, A.M.; Imbach, J L.; Schinazi, R.F., J. Med. Chem., 1989, 32, 73-76.
33. 34. Baker, B.R.; Tanna, P. M. J. Org. Chem. 1965, 30, 2857-2858.
34. 35. Lira, E. P.; Huffman, C. W. J. Org. Chem. 1966, 31, 2188-2191
35. 36. Geen, G.R.; Kincey, P. M. Tetrahedron Lett., 1992, 33, 4609-4612.
36. 37. Witvrouw, M.; Schols, D.; Andrei, G.; Snoeck, R.; Ikeda, S.; Pauwels, R.; Van Schepdael, A.; Arnout, J.; Claes, P.; Desmyter, J.; De Clercq, E. Antiviral Chem. Chemother., 1992, 3, 351-360.